Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel

Biotechnology

Alector

Alector's headquarters in South San Francisco, CA, United States

Arnon Rosenthal

Kristina Cutter

Kevin McCauley

Jason Carlton

Lauren Cheney

Virginia Dejesus-Rueff

Hua Long

Marc Grasso

Neil Berkley

Giacomo Salvadore

Brian Sander

Danielle Pasqualone

Senior Vice President Research

Adam Boxer

Tillman Gerngross

Louis J. Lavigne Jr

Terry Mcguire

Richard H. Scheller

David Wehner

Kristine Yaffe

Marco Colonna

Stephen Hauser

Michael Heneka

Lewis Lanier

Liqun Luo

Thomas Christian Südhof

Robert Vassar

The Scientific Research Team at Alector is focused on pioneering advancements in neuroimmunology and antibody technology to develop innovative therapeutic solutions for neurological diseases. Comprising a diverse array of expertise, including protein engineering, genomics, and in-vivo pharmacology, the team conducts rigorous research to advance drug discovery, refine biomarker identification, and optimize therapeutic efficacy through cutting-edge methodologies. Their collaborative efforts drive the translation of scientific insights into impactful treatments for patients.

Scientific Research Team

The Leadership Team at Alector is responsible for guiding the strategic direction and operational management of the company. Comprising senior executives from finance, legal, clinical development, and scientific research, the team collaborates to oversee the development of innovative therapies, ensure regulatory compliance, and optimize financial performance, ultimately driving Alector's mission to advance neuroimmunology and improve patient outcomes.

Leadership Team

The Clinical Development Team at Alector is responsible for designing, overseeing, and executing clinical trials that evaluate the safety and efficacy of innovative therapeutics targeting neurodegenerative diseases. This team ensures regulatory compliance, manages trial operations, analyzes clinical data, and collaborates across departments to advance the company’s groundbreaking research in neuroimmunology and human genetics. Their work is integral to progressing Alector's pipeline from preclinical stages to successful clinical outcomes.

Clinical Development Team

The Finance and Legal Team at Alector is responsible for ensuring the company's financial health and legal compliance. This team oversees financial planning, accounting operations, and regulatory reporting, while also managing intellectual property and corporate law matters. Their expertise enables Alector to navigate complex financial landscapes and protect its innovative developments in neuroscience.

Finance and Legal Team

The Manufacturing and Operations Team at Alector is responsible for overseeing the end-to-end production of biologics, ensuring efficient processes in antibody manufacturing and cell culture development. This team collaborates across various departments to maintain regulatory compliance, manage supply chain logistics, and implement quality control measures, all aimed at advancing innovative therapeutic solutions in neuroimmunology. Their expertise enables the seamless transition from discovery to clinical development while supporting the organization’s strategic objectives.

Manufacturing and Operations Team

This department manages and oversees clinical development, biostatistics, and quality assurance within the nonclinical and clinical sciences domains.

Clinical Science Operations

Alector

Org chart

Board & advisors

Teams

Scientific Research Team

Leadership Team

Clinical Development Team

Finance and Legal Team

Manufacturing and Operations Team

Clinical Science Operations

Offices

Alector

Org chart

Board & advisors

Teams

Scientific Research Team

Leadership Team

Clinical Development Team

Finance and Legal Team

Manufacturing and Operations Team

Clinical Science Operations

Offices

Related companies